Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Infectious Diseases

• Publication date

  2013-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jis720PMID 23204164PMCID PMC3549598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 19th Conference on Retroviruses and Opportunistic Infections

  2012cited by this paper
• HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue.

  2012cited by this paper
• Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

  2011cited by this paper
• Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.

  2011influential reference
• Short communication: transplacental nucleoside analogue exposure and mitochondrial parameters in HIV-uninfected children.

  2011cited by this paper
• Mitochondrial damage in adipose tissue of untreated HIV-infected patients

  2011cited by this paper
• Comparison of Dorsocervical With Abdominal Subcutaneous Adipose Tissue in Patients With and Without Antiretroviral Therapy–Associated Lipodystrophy

  2011cited by this paper
• Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells

  2010cited by this paper
• Differential modulation of mitochondrial OXPHOS system during HIV-1 induced T-cell apoptosis: up regulation of Complex-IV subunit COX-II and its possible implications

  2009cited by this paper
• Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

  2009cited by this paper
• Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection

  2008cited by this paper
• Linezolid-induced inhibition of mitochondrial protein synthesis.

  2006cited by this paper
• A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy

  2006cited by this paper
• Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process.

  2005cited by this paper
• Mitochondrial complex I activity is impaired during HIV-1-induced T-cell apoptosis

  2005cited by this paper
• Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.

  2004cited by this paper
• Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study

  2004cited by this paper
• Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study.

  2004cited by this paper
• Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies.

  2004cited by this paper
• Depletion of mitochondrial DNA in HIV‐1‐infected patients and its amelioration by antiretroviral therapy

  2003cited by this paper
• Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies.

  2002cited by this paper

• Mitochondrial DNA Variation, Antiretroviral Therapy, and Incidence of Diabetes Among Men With and Without HIV

  2026cites this paper
• Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.

  2026cites this paper
• Menopause is associated with faster increases in insulin resistance in women with HIV.

  2025cites this paper
• Differential effects of switching to integrase strand transfer inhibitors on the gut microbiota and markers of HIV disease progression

  2025cites this paper
• Gluteal adipose tissue mitochondrial respiration and insulin sensitivity in pregnant South African women living with HIV on Tenofovir-Lamivudine-Dolutegravir.

  2025cites this paper
• Maintenance therapy with dolutegravir and lamivudine versus bictegravir, emtricitabine, and tenofovir alafenamide in people with HIV (PASO-DOBLE): 48-week results from a randomised, multicentre, open-label, non-inferiority trial.

  2025cites this paper
• Impact of different INSTIs on BMI among people living with HIV who newly started ART in Shenzhen, China: a real-world data analysis.

  2025cites this paper
• Beyond viral suppression: decoding the mitochondrial-immune axis in HIV-associated inflammation and immune dysfunction

  2025cites this paper
• Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection

  2024cites this paper
• Switch to Integrase Strand Transfer Inhibitors during the Menopausal Transition is Associated with Accelerated Body Composition Change in Women with HIV.

  2024cites this paper
• Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

  2024cites this paper
• Oxidative phosphorylation in HIV-1 infection: impacts on cellular metabolism and immune function

  2024cites this paper
• Sarcopenia risk, sarcopenia-related quality of life, and associated factors in people living with human immunodeficiency virus (HIV): A web-based survey.

  2024cites this paper
• Highlights from the 30th Conference on Retroviruses and Opportunist Infections (CROI)

  2023cites this paper
• Prevalence and risk factors of metabolic syndrome in Ethiopia: describing an emerging outbreak in HIV clinics of the sub-Saharan Africa – a cross-sectional study

  2023cites this paper
• Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications

  2023cites this paper
• Weight Gain in People with HIV: The Role of Demographics, Antiretroviral Therapy, and Lifestyle Factors on Weight

  2023cites this paper
• Altered methionine-sulfone levels are associated with impaired growth in HIV-exposed-uninfected children

  2023cites this paper
• Moringa oleifera Lam Leaf Extract Stimulates NRF2 and Attenuates ARV-Induced Toxicity in Human Liver Cells (HepG2)

  2023cites this paper
• Update in Human Immunodeficiency Virus and Aging.

  2023cites this paper
• Biological ageing with HIV infection: evaluating the geroscience hypothesis

  2022cites this paper
• The Potential of Moringa oleifera to Ameliorate HAART-Induced Pathophysiological Complications

  2022influential citation
• Lipidome Alterations with Exercise Among People With and Without HIV: An Exploratory Study

  2022cites this paper
• Chronic HIV Infection and Aging: Application of a Geroscience-Guided Approach

  2022cites this paper
• Cardiometabolic Complications in Youth With Perinatally Acquired HIV in the Era of Antiretroviral Therapy

  2021cites this paper
• Long-term treated HIV infection is associated with platelet mitochondrial dysfunction

  2021cites this paper
• Increased risk of prediabetes among virally suppressed adults with HIV in Central Kenya detected using glycated haemoglobin and fasting blood glucose

  2021cites this paper
• Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter?

  2021cites this paper
• Subcutaneous Adipocyte Adenosine Triphosphate Levels in HIV Infected Patients

  2020cites this paper
• Pathogenesis of Aging and Age-related Comorbidities in People with HIV: Highlights from the HIV ACTION Workshop

  2020cites this paper
• African Mitochondrial DNA Haplogroup L2 is Associated with Slower Decline of β-Cell Function and Lower Incidence of Diabetes Mellitus in non-Hispanic Black Women with HIV.

  2020cites this paper
• Mitochondrial Dysfunction and Insulin Resistance in Pubertal Youth Living with Perinatally Acquired HIV

  2020cites this paper
• Relationships Between Adipose Mitochondrial Function, Serum Adiponectin, and Insulin Resistance in Persons With HIV After 96 Weeks of Antiretroviral Therapy

  2019cites this paper
• CT Fat Density Accurately Reflects Histologic Fat Quality in Adults with HIV On and Off Antiretroviral Therapy.

  2019cites this paper
• Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

  2019cites this paper
• Examining Relationships between Metabolism and Persistent Inflammation in HIV Patients on Antiretroviral Therapy

  2018cites this paper
• Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update

  2018cites this paper
• Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy

  2018cites this paper
• Geriatric syndromes: new frontiers in HIV and sarcopenia

  2017cites this paper
• Adipose Tissue in HIV Infection.

  2017cites this paper
• Effects of ART in HIV Infected Population on Body Habitus Change: A Multilevel Meta-analysis

  2017cites this paper
• Monocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected women

  2017cites this paper
• Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy

  2017cites this paper
• The Use of Cytochrome C Oxidase Enzyme Activity and Immunohistochemistry in Defining Mitochondrial Injury in Kidney Disease

  2016cites this paper
• DIDANOSINE RETINAL TOXICITY.

  2016cites this paper
• Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s.

  2016cites this paper
• Fat Matters: Understanding the Role of Adipose Tissue in Health in HIV Infection

  2016cites this paper
• DIDANOSINE RETINAL TOXICITY.

  2016cites this paper
• Mitochondrial and apoptotic in vitro modelling of differential HIV-1 progression and antiretroviral toxicity.

  2015cites this paper
• Antiretroviral therapy management and rationalisation of available resources.

  2015cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Metabolic and body composition effects of newer antiretrovirals in HIV-infected patients

  2014cites this paper
• Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study

  2014influential citation
• Aging of the human innate immune system in HIV infection.

  2014cites this paper
• Metabolic disease in HIV infection.

  2013cites this paper
• Mitochondrial CSA and CSB: protein interactions and protection from ageing associated DNA mutations.

  2013cites this paper